Cytomegalovirus Treatment in Solid Organ Transplantation: An Update on Current Approaches
CONCLUSIONS: Selection of CMV antiviral treatment should be determined by patient-specific factors, including severity of illness, resistant or refractory disease, dose-limiting adverse effects, and the preferred route of administration.PMID:38501850 | DOI:10.1177/10600280241237534
Source: The Annals of Pharmacotherapy - Category: Drugs & Pharmacology Authors: Karen L Hardinger Daniel C Brennan Source Type: research
More News: Clinical Trials | Cytomegalovirus | Databases & Libraries | Drugs & Pharmacology | Encephalitis | Gastritis | Gastroenterology | Study | Toxicology | Transplants